Ipsoprubart

伊普索扑拜单抗

Report date: 2026/04/16 20:00:17

Base Information

Drug NameIpsoprubart
Drug Alias NameELA-026
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionSignal-regulatory protein alpha inhibitors
TargetsSignal-regulatory protein alpha
Therapy Area/IndicationsLymphohistiocytosis, HemophagocyticNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsItaly +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesElectra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesElectra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLymphohistiocytosis, HemophagocyticNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A